Related references
Note: Only part of the references are listed.The FKBP5-gene in depression and treatment response -: An association study in the sequenced treatment alternatives to relieve depression (STAR*D) cohort
Magnus Lekman et al.
BIOLOGICAL PSYCHIATRY (2008)
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults
Elisabeth B. Binder et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
β-catenin overexpression in the mouse brain phenocopies lithium-sensitive Behaviors
Todd D. Gould et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics
Kelley C. O'Donnell et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51
J. M. Westberry et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness
MP Boyle et al.
JOURNAL OF NEUROSCIENCE (2006)
Learned helplessness: Validity and reliability of depressive-like states in mice
S Chourbaji et al.
BRAIN RESEARCH PROTOCOLS (2005)
Bag1 is essential for differentiation and survival of hematopoietic and neuronal cells
R Götz et al.
NATURE NEUROSCIENCE (2005)
Functional impairment in the remission phase of bipolar disorder
A Fagiolini et al.
BIPOLAR DISORDERS (2005)
The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers
R Zhou et al.
JOURNAL OF NEUROSCIENCE (2005)
The stress system in the human brain in depression and neurodegeneration
DF Swaab et al.
AGEING RESEARCH REVIEWS (2005)
Interaction of BAG1 and Hsp70 mediates neuroprotectivity and increases chaperone activity
J Liman et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers
A Camacho et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Bipolar disorder and health-related quality of life - Review of burden of disease and clinical trials
DA Revicki et al.
PHARMACOECONOMICS (2005)
Forced swimming test in mice: a review of antidepressant activity
B Petit-Demouliere et al.
PSYCHOPHARMACOLOGY (2005)
Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats
T Itoh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Glucocorticoid receptor overexpression in forebrain: A mouse model of increased emotional lability
Q Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Medical progress: Bipolar disorder
RH Belmaker
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
EB Binder et al.
NATURE GENETICS (2004)
The McLean-Harvard first-episode mania study: Prediction of recovery and first recurrence
M Tohen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Bag1 is a regulator and marker of neuronal differentiation
P Kermer et al.
CELL DEATH AND DIFFERENTIATION (2002)
The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth
PX Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
